Skip to content
10-K

Annual Report

NIKA PHARMACEUTICALS, INC NIKA

0001826466-24-000041

← back to feed
Filed
Apr 1, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 22, 2024 876.09M sh
Revenue FY 2023 · Dec 31, 2023 $0
Operating Cash Flow FY 2023 · Dec 31, 2022 $33.72K
Cash And Equivalents FY 2023 · Dec 31, 2022 $864
Current Liabilities FY 2023 · Dec 31, 2022 $18.18K
Total Liabilities FY 2023 · Dec 31, 2022 $18.18K
Current Assets FY 2023 · Dec 31, 2022 $864
Total Assets FY 2023 · Dec 31, 2022 $864
Eps Basic FY 2023 · Dec 31, 2022 $0.00
Sga Expense FY 2023 · Dec 31, 2022 $33.72K
Net Income FY 2023 · Dec 31, 2022 −$3.18M
Operating Income FY 2023 · Dec 31, 2022 −$3.18M
Stockholders Equity FY 2023 · Dec 31, 2021 −$23.62K